HTA319 The Impact of Clinical Evidence on the Inclusion of Non-Small Cell Lung Cancer Drugs in Brazil's Supplementary Healthcare System
Abstract
Authors
Luiza Osuna Falavigna Larissa Faia Franciele Iachecen Iara Muller Bernz Cristhiane Gennaro Simões